Efficacy and Safety Profile of Monoclonal Antibodies in Severe Allergic Asthma Management
Recent clinical trials demonstrate that targeted biologic therapy significantly reduces annualized exacerbation rates and improves quality of life in patients with severe uncontrolled allergic asthma.
Dr. Eleanor Vance
Elsevier, 2026



